J&J Says A Booster Shot For Its Vaccine May Have Big Benefits

A nurse fills a syringe with Johnson & & Johnsons COVID-19 vaccine at a clinic in Pasadena, Calif., on Thursday.

Robyn Beck/AFP through Getty Images

conceal caption

toggle caption

Robyn Beck/AFP through Getty Images

A nurse fills a syringe with Johnson & & Johnsons COVID-19 vaccine at a center in Pasadena, Calif., on Thursday.

Robyn Beck/AFP through Getty Images

The pharmaceutical giant said in a news release Wednesday that when it offered individuals in a study a second jab of its coronavirus vaccine after six months, their antibody levels were 9 times higher than 28 days after their first dose. “With these brand-new information, we also see that a booster dosage of the Johnson & & Johnson COVID-19 vaccine further increases antibody reactions amongst research study participants who had previously received our vaccine,” he added. Individuals 18 years and older who got the Pfizer or Moderna vaccines will be eligible for a booster dose 8 months after their second dosage. Just over 14 million people have actually gotten the Johnson & & Johnson vaccine, the tiniest share amongst the 3 vaccines being utilized in the U.S., according to the Centers for Disease Control and Prevention. “It would be affordable to say that yes, have at least 2 dosages of J&J, or have at least one more dosage for those who had a single dose, consisting of the alternative of having another J&J,” said Saad Omer, a vaccine scientist at Yale.

” We have actually established that a single shot of our COVID-19 vaccine generates robust and strong immune actions that are durable and persistent through 8 months,” stated Mathai Mammen, worldwide head of Janssen Research & & Development, Johnson & & Johnson, in a statement. “With these new data, we likewise see that a booster dosage of the Johnson & & Johnson COVID-19 vaccine further increases antibody actions among research study individuals who had actually previously received our vaccine,” he included. The information have actually not yet been released in a scientific journal or reviewed by other researchers.

The World Health Organization has actually contacted countries to delay their plans for booster shots till nations with lower vaccination rates can inoculate more of their population. Just over 14 million people have actually received the Johnson & & Johnson vaccine, the tiniest share amongst the three vaccines being used in the U.S., according to the Centers for Disease Control and Prevention. The Pfizer vaccine has been administered to more than 205 million people, and almost 144 million have actually gotten the Moderna shot, the CDC stated.

The Biden administration has currently announced strategies to begin rolling out boosters in September for individuals who received the Moderna and Pfizer vaccines. Individuals 18 years and older who got the Pfizer or Moderna vaccines will be qualified for a booster dosage 8 months after their 2nd dosage.

Several independent scientists said the finding would most likely support offering individuals boosters with the Johnson & & Johnson vaccine. “It would be sensible to state that yes, have at least 2 dosages of J&J, or have at least one more dose for those who had a single dosage, consisting of the option of having another J&J,” said Saad Omer, a vaccine researcher at Yale. “It is pointing toward the utility of a second dose.

Johnson & & Johnson states it has proof that people who received its one-shot COVID-19 vaccine could take advantage of a booster shot after six months. The pharmaceutical giant stated in a news release Wednesday that when it provided participants in a study a second jab of its coronavirus vaccine after six months, their antibody levels were nine times higher than 28 days after their first dose. The information suggests that an extra shot might function as a booster if the vaccines effectiveness begins to wane.

Leave a Reply

Your email address will not be published. Required fields are marked *